Active versus standard sun protection in patients with melanoma stage I or II: A randomised controlled feasibility trial assessing compliance with sun protection and quality of life.

Active versus standard sun protection in patients with melanoma stage I or II: A randomised controlled feasibility trial assessing compliance with sun protection and quality of life.
Br J Dermatol. 2020 Jul 11;:
Authors: Goeth H, Koller M, Hegemann MV, Drexler K, Zeman F, Huppertz G, Berneburg M, Maisch T
Abstract
The incidence of melanoma is steadily increasing in the Western hemisphere, and one key factor is UV exposure. Sun protection is essential, particularly in patients with diagnosed melanoma. However, data on the psychological implications of sunscreen protection in melanoma patients are lacking. This project was designed as a randomised controlled feasibility trial to explore the feasibility of the diary method and tube count to assess patient compliance in the setting of a monocentric trial, furthermore to observe any recognisable trends regarding anxiety and QoL between the intervention and control group.
PMID: 32652591 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - July 10, 2020 Category: Dermatology Authors: Goeth H, Koller M, Hegemann MV, Drexler K, Zeman F, Huppertz G, Berneburg M, Maisch T Tags: Br J Dermatol Source Type: research